IGF-1 LR3

Description

IGF-1 LR3 (Insulin-like Growth Factor 1 Long Arg3) is a synthetic analogue of IGF-1, modified with an arginine substitution at position 3 and a 13-amino-acid N-terminal extension to significantly reduce IGF-binding protein affinity. In research settings, IGF-1 LR3 is studied for its prolonged IGF-1 receptor engagement and downstream anabolic signaling pathway activation.

BioRhex supplies IGF-1 LR3 as a research compound manufactured in a GMP-compliant US facility, tested to ≥99% purity via HPLC and mass spectrometry, and supplied strictly for controlled laboratory research — not for human or animal use.